Cite
MLA Citation
A Manzaneque et al.. “DI-010 Factors influencing the appearance of haematological and thyroid adverse effects in patients with hepatitis C virus genotype 1 treated with telaprevir/boceprevir plus peg-interferon and ribavirin.” European journal of hospital pharmacy, vol. 22, n.d., p. A79. http://access.bl.uk/ark:/81055/vdc_100172521815.0x000048